Related Experiment Video
Updated: May 5, 2026
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
8.7K
SIRT2 versus Lck
1Science Signaling, AAAS, Washington, DC 20005, USA.
Science Signaling
|February 10, 2026
Summary
Inhibiting SIRT2 deacetylase activity boosts Lck kinase function. This enhances T cell receptor signaling, crucial for immune responses.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- T cell receptor (TCR) signaling is vital for adaptive immunity.
- SIRT2 is a deacetylase enzyme implicated in various cellular processes.
- Lck is a key kinase in the TCR signaling pathway.
Purpose of the Study:
- To investigate the regulatory role of SIRT2 in T cell activation.
- To determine the effect of SIRT2 inhibition on Lck kinase activity.
- To elucidate the impact on downstream TCR signaling.
Main Methods:
- Utilized chemical inhibitors to block SIRT2 deacetylase activity in T cells.
- Assessed Lck kinase phosphorylation levels via Western blotting.
- Measured TCR signaling pathway activation through cytokine production assays.
Main Results:
- SIRT2 inhibition led to increased Lck kinase activity.
- Enhanced Lck activity correlated with augmented TCR signaling.
- Specific deacetylation targets of SIRT2 influencing Lck were identified.
Conclusions:
- SIRT2 negatively regulates Lck kinase activity.
- Inhibiting SIRT2 represents a potential strategy to boost T cell responses.
- Targeting SIRT2 could have implications for immunotherapies.
Related Concept Videos
01:45Regulation of Nuclear Protein Sorting
2.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:26Receptor Tyrosine Kinases
15.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
01:20The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K